Literature DB >> 25598551

Differences in Substance Abuse Counselors' Knowledge of Tobacco Cessation Medication Effectiveness: 2002-2008.

Tanja C Rothrauff1, Amanda J Abraham2, Paul M Roman3.   

Abstract

Counselors play a supportive role in patients' substance abuse treatment, including tobacco cessation. Thus, counselors should be knowledgeable about tobacco cessation medications (TCMs). This study examined differences in counselors' knowledge of and familiarity with (i.e., diffusion) bupropion and nicotine replacement therapy (NRT) between 2002 and 2008 and identified predictors of diffusion. Repeated cross-sectional questionnaire data were obtained in 2002/04 from 992 counselors and in 2007/08 from 1,226 counselors working in private treatment programs. Results indicated that more counselors in 2007/08 did not know about bupropion to rate its effectiveness than in 2002/04; no differences were found for NRT. Among both samples of counselors who were familiar with TCMs, effectiveness was rated higher in 2007/08 than in 2002/04. Findings suggest that educated and trained counselors are important in diffusing TCMs. Knowledgeable counselors may be able to educate patients interested in tobacco cessation about available treatments and encourage compliance with TCMs.

Entities:  

Year:  2011        PMID: 25598551      PMCID: PMC4295208          DOI: 10.1177/002204261104100107

Source DB:  PubMed          Journal:  J Drug Issues        ISSN: 0022-0426


  16 in total

1.  A discussion of the concept of technology transfer of research-based drug "abuse" prevention and treatment interventions.

Authors:  Zili Sloboda; Sam Schildhaus
Journal:  Subst Use Misuse       Date:  2002 Jun-Aug       Impact factor: 2.164

2.  Survey of smoking cessation services in Canadian addiction programs.

Authors:  Shawn R Currie; Kelly Nesbitt; Cathy Wood; Andrea Lawson
Journal:  J Subst Abuse Treat       Date:  2003-01

3.  Attitudes toward the integration of smoking cessation treatment into drug abuse clinics.

Authors:  Bret E Fuller; Joseph Guydish; Janice Tsoh; Malcolm S Reid; Michael Resnick; Lucy Zammarelli; Douglas M Ziedonis; Clare Sears; Dennis McCarty
Journal:  J Subst Abuse Treat       Date:  2006-09-26

4.  Efficacy of varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation: a randomized controlled trial.

Authors:  Douglas E Jorenby; J Taylor Hays; Nancy A Rigotti; Salomon Azoulay; Eric J Watsky; Kathryn E Williams; Clare B Billing; Jason Gong; Karen R Reeves
Journal:  JAMA       Date:  2006-07-05       Impact factor: 56.272

5.  Tobacco use and quit attempts among methadone maintenance clients.

Authors:  K P Richter; C A Gibson; J S Ahluwalia; K H Schmelzle
Journal:  Am J Public Health       Date:  2001-02       Impact factor: 9.308

6.  Research to practice: adoption of naltrexone in alcoholism treatment.

Authors:  Cindy Parks Thomas; Stanley S Wallack; Sue Lee; Dennis McCarty; Robert Swift
Journal:  J Subst Abuse Treat       Date:  2003-01

7.  Counselor attitudes toward pharmacotherapies for alcohol dependence.

Authors:  Amanda J Abraham; Lori J Ducharme; Paul M Roman
Journal:  J Stud Alcohol Drugs       Date:  2009-07       Impact factor: 2.582

8.  Adoption and implementation of new technologies in substance abuse treatment.

Authors:  Paul M Roman; J Aaron Johnson
Journal:  J Subst Abuse Treat       Date:  2002-06

9.  Mortality following inpatient addictions treatment. Role of tobacco use in a community-based cohort.

Authors:  R D Hurt; K P Offord; I T Croghan; L Gomez-Dahl; T E Kottke; R M Morse; L J Melton
Journal:  JAMA       Date:  1996-04-10       Impact factor: 56.272

10.  Cigarette smoking cessation services in outpatient substance abuse treatment programs in the United States.

Authors:  Peter D Friedmann; Lan Jiang; Kimber P Richter
Journal:  J Subst Abuse Treat       Date:  2007-05-23
View more
  1 in total

1.  Counselor attitudes toward the use of naltrexone in substance abuse treatment: a multi-level modeling approach.

Authors:  Amanda J Abraham; Traci Rieckmann; Thomas McNulty; Anne E Kovas; Paul M Roman
Journal:  Addict Behav       Date:  2011-01-28       Impact factor: 3.913

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.